Authors: Tutunji, M Jarrar, O Musameh, M Alam, SM",Quamruzaman,"Dham, R

Citation: M. Tutunji et al., Bioequivalence evaluation of two brands of cefaclor 500 mg capsules: quantification of cefaclor using solid phase extraction technique, J CLIN PH T, 26(2), 2001, pp. 149-153

Authors: Najib, NM Idkaidek, N Ghanem, IE Admour, I Alam, SM Zaman, Q Dham, R

Citation: Nm. Najib et al., Bioequivalence assessment of Azomycin (R) (Julphar, UEA) as compared with Zithromax (R) (Pfizer, USA) - Two brands of azithromycin - In healthy humanvolunteers, BIOPHARM DR, 22(1), 2001, pp. 15-21

Authors: Al-Said, MS Al-Khamis, KI Niazy, EM El-Sayed, YM Al-Rashood, KA Al-Bella, S Al-Yamani, MA Al-Najjar, TA Alam, SM Dham, R Qumaruzaman, QZ

Citation: Ms. Al-said et al., Bioequivalence evaluation of two brands of cefuroxime 500 mg tablets (Cefuzime((R)) and Zinnat((R))) in healthy human volunteers, BIOPHARM DR, 21(6), 2000, pp. 205-210

Authors: Al-Rashood, KA Al-Khamis, KI El-Sayed, YM Al-Bella, S Al-Yamani, MA Alam, SM Dham, R

Citation: Ka. Al-rashood et al., Bioequivalence evaluation of norfloxacin 400 mg tablets (Uroxin (R) and Noroxin (R)) in healthy human volunteers, BIOPHARM DR, 21(5), 2000, pp. 175-179

Authors: Al-Rashood, KA Al-Khamis, KI El-Sayed, YM Al-Bella, S Al-Yamani, MA Alam, SM Dham, R

Citation: Ka. Al-rashood et al., Bioequivalence evaluation of lomefloxacin 400 mg tablets (Lomax((R)) versus Maxaquin((R))) in healthy human volunteers, BIOPHARM DR, 20(9), 1999, pp. 407-410